Combination immunotherapy shows promise for treating bladder cancer
Combination immunotherapy is producing response rates ranging from 26 to 38% among patients with metastatic bladder cancer in a...
What we can learn from revolutionary melanoma treatment
The largest analysis of metastatic melanoma patients who received a targeted therapy combination shows the treatment provides...
Molecular testing used to find the best clinical trial for...
A new trial underway at MD Anderson may lead to new therapies for triple negative breast cancer.
Fifteen to 20% of breast cancers...
Predicting if cancer patients will develop highly fatal leukemia
Patients who’ve been successfully treated for breast, colon and other cancers can go on to develop an often-fatal form of leukemia,...
Most salons are complying with tanning bed ban — an...
When female employees of a mystery shopping firm called posing as 17-year-olds interested in tanning, 81% of indoor tanning facilities...
MD Anderson is bringing greater access to advanced cancer...
The University of Texas Health Science Center at San Antonio and The University of Texas MD Anderson Cancer Center are announcing...
Screening program helps save an uninsured man’s life
Three years ago, Stephen Cadmus faced a dilemma. He needed to see a doctor, but he had no health insurance.
To get the medical...